Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
Ikesue H, Kusuda K, Satsuma Y, Nishiwaki F, Miura R, Masuda Y, Hirabatake M, Muroi N, Fujimoto D, Morimoto T, Tomii K, Hashida T. Ikesue H, et al. Among authors: hashida t. J Clin Pharm Ther. 2020 Dec;45(6):1288-1294. doi: 10.1111/jcpt.13207. Epub 2020 Jun 10. J Clin Pharm Ther. 2020. PMID: 32519774 Free PMC article.
Population pharmacokinetics of favipiravir in patients with COVID-19.
Irie K, Nakagawa A, Fujita H, Tamura R, Eto M, Ikesue H, Muroi N, Fukushima S, Tomii K, Hashida T. Irie K, et al. Among authors: hashida t. CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1161-1170. doi: 10.1002/psp4.12685. Epub 2021 Aug 17. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34292670 Free PMC article.
Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
Ikesue H, Yamaoka K, Matsumoto A, Hirabatake M, Muroi N, Yamasaki T, Kawakita M, Hashida T. Ikesue H, et al. Among authors: hashida t. Cancer Chemother Pharmacol. 2022 Jun;89(6):833-838. doi: 10.1007/s00280-022-04408-4. Epub 2022 Mar 7. Cancer Chemother Pharmacol. 2022. PMID: 35254504 Free PMC article.
Association between 25-hydroxyvitamin D levels and COVID-19 severity.
Takase T, Tsugawa N, Sugiyama T, Ikesue H, Eto M, Hashida T, Tomii K, Muroi N. Takase T, et al. Among authors: hashida t. Clin Nutr ESPEN. 2022 Jun;49:256-263. doi: 10.1016/j.clnesp.2022.04.003. Epub 2022 Apr 9. Clin Nutr ESPEN. 2022. PMID: 35623823 Free PMC article.
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
Tamura R, Irie K, Nakagawa A, Muroi H, Eto M, Ikesue H, Muroi N, Fukushima S, Tomii K, Hashida T. Tamura R, et al. Among authors: hashida t. CPT Pharmacometrics Syst Pharmacol. 2023 Apr;12(4):513-521. doi: 10.1002/psp4.12936. Epub 2023 Feb 22. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36798006 Free PMC article.
212 results